Recombinant Human BRCA2 Protein (HEK293)，Flag & Strep

The BRCA2 protein, a crucial component in the maintenance of genomic stability, is part of the homology-directed repair (HDR) pathway crucial for the repair of double-strand breaks in DNA. Mutations in the BRCA2 gene are primarily linked to increased susceptibility to breast and ovarian cancers, making it a significant focus in cancer genetics. Research into BRCA2 has revealed its critical role in the recruitment and regulation of DNA repair machinery, specifically the RAD51 protein, which is vital for the repair process. Furthermore, understanding the structural and functional dynamics of BRCA2 protein interactions has illuminated its role in maintaining chromosomal integrity. Advances in techniques such as X-ray crystallography and cryo-electron microscopy have provided insights into the protein's multi-domain architecture and its mechanisms of action. The study of BRCA2 not only enhances our comprehension of hereditary cancer predisposition but also has profound implications for the development of targeted therapies and personalized medicine, particularly in the realm of PARP inhibitors, which exploit the synthetic lethality associated with BRCA2 deficiency. This ongoing research underscores the importance of BRCA2 in cancer biology and its potential as a therapeutic target, contributing to the broader understanding of genetic factors in cancer development and treatment.